16
Participants
Start Date
July 22, 2019
Primary Completion Date
September 27, 2019
Study Completion Date
IMP4297
10mg/capsule.
Shanghai Public Health Clinical Center, Shanghai
Lead Sponsor
Impact Therapeutics, Inc.
INDUSTRY